Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

NCT03201861 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

762

Enrollment

OTHER

Sponsor class

Conditions

Tubular Breast Cancer
Mucinous Breast Cancer
Invasive Duct Carcinoma of Breast

Interventions

DRUG: Paclitaxel, Cisplatin
DRUG: EC to docetaxel or paclitaxel

Sponsor

RenJi Hospital